当前位置:首页 - 行情中心 - 重药控股(000950) - 财务分析

重药控股

(000950)

  

流通市值:92.46亿  总市值:92.46亿
流通股本:17.28亿   总股本:17.28亿

重药控股(000950)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润5.32亿元,每股收益0.22元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1647427.94万元,未分配利润737484.78万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产6771245.92万元,负债5123817.98万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入62,211,401,881.2741,188,217,331.8420,612,096,609.1880,561,531,747.38
营业总成本61,116,440,262.4940,415,012,353.6420,226,976,660.0879,839,411,726.2
其他经营收益
营业利润665,170,780.07471,401,348.72214,020,790.04562,641,037.67
利润总额657,436,219.76467,244,638.68211,332,204.89557,508,247.45
净利润532,377,823.31388,988,353.43172,505,204.48401,791,459.73
每股收益
其他综合收益-7,482,030.39-13,831,098.39--21,981,302.9
综合收益总额524,895,792.92375,157,255.04172,505,204.48379,810,156.83
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计58,455,643,236.5458,745,268,530.3359,202,757,740.7557,419,911,732.87
非流动资产:
非流动资产合计9,256,815,940.879,205,279,270.349,300,556,134.689,210,418,009.23
资产总计67,712,459,177.4167,950,547,800.6768,503,313,875.4366,630,329,742.1
流动负债:
流动负债合计47,396,940,496.5746,434,905,935.446,382,274,689.9444,063,870,997.17
非流动负债:
非流动负债合计3,841,239,275.294,943,404,111.965,447,200,473.96,103,014,107.41
负债合计51,238,179,771.8651,378,310,047.3651,829,475,163.8450,166,885,104.58
所有者权益(或股东权益):
归属于母公司股东权益合计11,556,221,592.6711,529,245,977.0511,443,450,307.1811,327,166,544.56
股东权益合计16,474,279,405.5516,572,237,753.3116,673,838,711.5916,463,444,637.52
负债和股东权益合计67,712,459,177.4167,950,547,800.6768,503,313,875.4366,630,329,742.1
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计66,990,294,029.2244,296,901,750.4420,761,939,735.6291,245,572,738.15
经营活动现金流出小计69,320,559,190.6246,570,392,113.3222,926,477,104.0591,432,309,861.29
经营活动产生的现金流量净额-2,330,265,161.4-2,273,490,362.88-2,164,537,368.43-186,737,123.14
投资活动产生的现金流量:
投资活动现金流入小计235,235,365.76139,429,169.621,501,196.21265,254,837.2
投资活动现金流出小计296,998,614.76184,428,713.08107,332,680.81447,718,900.06
投资活动产生的现金流量净额-61,763,249-44,999,543.46-105,831,484.6-182,464,062.86
筹资活动产生的现金流量:
筹资活动现金流入小计17,966,913,059.0111,784,996,964.245,189,064,692.6225,574,397,775.75
筹资活动现金流出小计18,635,288,653.8112,112,150,802.955,346,370,499.3525,526,063,664.85
筹资活动产生的现金流量净额-668,375,594.8-327,153,838.71-157,305,806.7348,334,110.9
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-3,060,404,005.2-2,645,643,745.05-2,427,674,659.76-320,867,075.1
期末现金及现金等价物余额1,726,578,569.042,141,338,829.192,359,307,914.484,786,982,574.24
补充资料:
现金及现金等价物的净增加额--2,645,643,745.05--320,867,075.1
最新报告期:2025-09-01
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西南证券杜向阳0.170.180.202025-09-01
招商证券方秋实,许菲菲0.200.240.252025-08-25
TOP↑